Verily’s COVID Testing Program Halted in San Francisco and Oakland
Health officials in San Francisco and Alameda counties have cut ties with Verily’s state-funded COVID testing sites amid concerns about data collection and privacy.
Inside the Flawed White House Testing Scheme That Did Not Protect Trump
President Trump relied heavily on testing as protection against COVID exposure, eschewing masks and social distancing.
El sistema de pruebas para COVID de la Casa Blanca no protegió al presidente
El diagnóstico de COVID-19 del presidente Donald Trump está generando nuevas preguntas sobre la estrategia de la Casa Blanca para realizar pruebas y contener la propagación del virus.
These Secret Safety Panels Will Pick the COVID Vaccine Winners
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
It’s Not Just Insulin: Lawmakers Focus on Price of One Drug, While Others Rise Too
While insulin is the poster child for outrageous prescription costs, patients are paying ever more to treat depression, asthma, HIV, cholesterol and more. And the pandemic has overtaken efforts to force the issue in Congress.
Lack of Antigen Test Reporting Leaves Country ‘Blind to the Pandemic’
A KHN review found more than 20 states either don’t count or have incomplete data on the use of COVID-19 antigen tests, leaving the public in the dark about the true scope of the pandemic.
Trump Is Sending Fast, Cheap COVID Tests to Nursing Homes — But There’s a Hitch
Experts say the administration’s approach with antigen tests could add cost and risk for the most vulnerable patients.
As Georgia Reopened, Officials Knew of Severe Shortage of PPE for Health Workers
State officials said they urgently needed millions more masks and gowns, internal emails show. At least 80 Georgia health workers have died from COVID-19, including after the state reopened its economy.
Business Is Booming for Dialysis Giant Fresenius. It Took a $137M Bailout Anyway.
Half of the money the Trump administration gave dialysis companies was collected by Fresenius, an international juggernaut with a robust balance sheet, a KHN analysis has found.
As Problems Grow With Abbott’s Fast COVID Test, FDA Standards Are Under Fire
After the FDA issues a public warning about the test, one of its senior officials says point-of-care coronavirus tests can miss 20% of cases and still be considered useful. Public health experts are split.